187 related articles for article (PubMed ID: 1650650)
61. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
62. The potentiation of phorbol ester-induced aggregation of human platelets by the prostaglandin endoperoxide analogue, U46619.
Edwards MC; Williamson EM; Evans FJ
J Pharm Pharmacol; 1987 May; 39(5):370-7. PubMed ID: 2886585
[TBL] [Abstract][Full Text] [Related]
63. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
Cho HJ; Cho JY; Rhee MH; Lim CR; Park HJ
J Pharm Pharmacol; 2006 Dec; 58(12):1677-82. PubMed ID: 17331333
[TBL] [Abstract][Full Text] [Related]
64. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Mais DE; Liel N; Halushka PV
Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
[TBL] [Abstract][Full Text] [Related]
65. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
66. Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cells.
Dorn GW; Davis MG
J Pharmacol Exp Ther; 1992 Sep; 262(3):1242-7. PubMed ID: 1527727
[TBL] [Abstract][Full Text] [Related]
67. Regulatory role of prostaglandin E2 in induction of cyclo-oxygenase-2 by a thromboxane A2 analogue (U46619) and basic fibroblast growth factor in porcine aortic smooth-muscle cells.
Karim S; Berrou E; Lévy-Toledano S; Bryckaert M; MacLouf J
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):593-9. PubMed ID: 9291137
[TBL] [Abstract][Full Text] [Related]
68. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.
Nakano T; Hanasaki K; Arita H
Thromb Res; 1989 Oct; 56(2):299-306. PubMed ID: 2617470
[TBL] [Abstract][Full Text] [Related]
69. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
70. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
[TBL] [Abstract][Full Text] [Related]
71. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
72. Effect of Kil769, a novel K(+)-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery.
Yokoyama T; Kasai H; Okada Y; Izumi H; Izawa T; Ogawa N
J Pharm Pharmacol; 1995 Feb; 47(2):148-51. PubMed ID: 7602470
[TBL] [Abstract][Full Text] [Related]
73. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M
Cell Biochem Funct; 1991 Apr; 9(2):79-85. PubMed ID: 1718622
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of platelet aggregation by monoclonal antibody reactive with beta 2-microglobulin chain of HLA complex.
Curry RA; Messner RP; Johnson GJ
Science; 1984 May; 224(4648):509-11. PubMed ID: 6324346
[TBL] [Abstract][Full Text] [Related]
75. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
76. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
Swann PG; Venton DL; Le Breton GC
FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230
[TBL] [Abstract][Full Text] [Related]
77. Thromboxane receptor stimulation inhibits adenylate cyclase and reduces cyclic AMP-mediated inhibition of ADP-evoked responses in fura-2-loaded human platelets.
Sage SO; Heemskerk JW
FEBS Lett; 1992 Feb; 298(2-3):199-202. PubMed ID: 1312024
[TBL] [Abstract][Full Text] [Related]
78. Measurement of thromboxane A2-induced elevation of ionized calcium in collagen-stimulated platelets with the photoprotein, aequorin.
Nakano T; Terawaki A; Arita H
J Biochem; 1986 Apr; 99(4):1285-8. PubMed ID: 3711064
[TBL] [Abstract][Full Text] [Related]
79. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors.
Turini ME; Gaudette DC; Holub BJ; Kirkland JB
Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513
[TBL] [Abstract][Full Text] [Related]
80. Effects of intracellular and extracellular calcium blockers on the pulmonary vascular responses to PGF2 alpha and U46619.
Santoian EC; Angerio AD; Fitzpatrick TM; Rose JC; Ramwell PW; Kot PA
Angiology; 1987 Jan; 38(1 Pt 1):51-5. PubMed ID: 3468816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
